D J McKenna1, S J Peroutka. Show Affiliations » 1. Department of Neurology, Stanford University School of Medicine, California 94305.
Abstract
Entities: Chemical Disease
Mesh: See more » 3,4-Methylenedioxyamphetamine/analogs & derivatives3,4-Methylenedioxyamphetamine/pharmacology3,4-Methylenedioxyamphetamine/toxicityAmphetamines/toxicityAnimalsBrain/drug effectsBrain/metabolismBrain/pathologyDesigner Drugs/toxicityN-Methyl-3,4-methylenedioxyamphetamineReceptors, Cell Surface/drug effectsReceptors, Cell Surface/metabolismSerotonin/metabolism
Substances: See more » AmphetaminesDesigner DrugsReceptors, Cell SurfaceSerotonin3,4-MethylenedioxyamphetamineN-Methyl-3,4-methylenedioxyamphetamine
Year: 1990 PMID: 1967141 DOI: 10.1111/j.1471-4159.1990.tb13277.x
Source DB: PubMed Journal: J Neurochem ISSN: 0022-3042 Impact factor: 5.372